Advancing Pharmaceutical Supply. Investing in Future Medicines.
Origin Group is building its pharmaceutical business through the supply of active pharmaceutical ingredients, pharmaceutical raw materials and plastic capsule shells, while exploring investment opportunities in API manufacturing and pharmaceutical research and development.
Building a Platform Across the Pharmaceutical Value Chain
Pharmaceutical manufacturing depends on reliable access to quality ingredients and essential production materials. Origin Group currently focuses on the supply of APIs, pharmaceutical raw materials and plastic capsule shells.
Alongside this commercial activity, we are looking toward the next stage of development: investing in API manufacturing capabilities and establishing a research laboratory focused on the development of new medicines.
From Pharmaceutical Supply to Manufacturing and Research
Our ambition is to explore opportunities across the pharmaceutical value chain, connecting product supply today with potential manufacturing and research capabilities for the future.
Investment decisions will be guided by technical feasibility, regulatory requirements, commercial demand and long-term business viability.
Pharmaceutical Products & Raw Materials
Our current product focus includes pharmaceutical ingredients and capsule-related materials for businesses operating within the pharmaceutical supply chain. Product specifications, grades and availability are subject to individual product documentation and confirmation.
Active Pharmaceutical Ingredients
Supply of active pharmaceutical ingredients used as the active components in pharmaceutical formulations, subject to product availability and applicable quality documentation.
Pharmaceutical Raw Materials
Supply of pharmaceutical raw materials used in manufacturing and formulation processes, based on specific product requirements, applicable specifications and availability.
Plastic Capsule Shells
Supply of plastic capsule shells for pharmaceutical applications, subject to the required product type, dimensions, specifications and intended use.
Developing Pharmaceutical Manufacturing Capabilities
Origin Group is exploring investment opportunities that could expand its participation from product supply into pharmaceutical manufacturing and scientific research. These are future investment priorities and are subject to feasibility, approvals, funding and project development.
API Manufacturing Facility
We are looking to evaluate the development of an active pharmaceutical ingredient manufacturing facility, with the objective of building production capabilities and serving suitable domestic and international markets.
- Assessment of API product opportunities and market demand
- Evaluation of manufacturing technologies and production processes
- Facility design, equipment and quality-system planning
- Environmental, safety and regulatory compliance planning
- Evaluation of domestic and export-market opportunities
Drug Research & Development Laboratory
We are exploring the development of a pharmaceutical research laboratory focused on scientific work that could support the development of new medicines and future pharmaceutical products.
- Research capability and laboratory infrastructure assessment
- Evaluation of formulation and analytical development capabilities
- Scientific talent, specialist teams and research partnerships
- Evaluation of suitable research and development programmes
- Planning for applicable quality, safety and regulatory standards
Exploring the Next Generation of Pharmaceutical Capabilities
Our longer-term vision is to evaluate opportunities that connect pharmaceutical supply, manufacturing and research. The precise research focus will be determined through scientific, commercial and regulatory assessment.
Analytical Development
Explore capabilities for testing, characterisation and analytical methods to support pharmaceutical development and quality evaluation.
Formulation Research
Evaluate formulation research opportunities for suitable pharmaceutical dosage forms, subject to scientific expertise and project feasibility.
Research Partnerships
Explore collaboration with qualified scientists, universities, contract research organisations and pharmaceutical technology partners where strategically appropriate.
A Structured Approach to Pharmaceutical Expansion
Pharmaceutical manufacturing and drug research require specialised infrastructure, qualified personnel, rigorous quality systems and regulatory oversight. Our approach is to evaluate each opportunity against clear technical and commercial requirements.
01. Market Assessment
Study product demand, competitive positioning, customer needs and potential market access.
02. Technical Feasibility
Evaluate processes, facilities, equipment, technical expertise and operational requirements.
03. Quality & Compliance
Identify applicable manufacturing, laboratory, environmental, safety and regulatory requirements.
04. Investment Evaluation
Assess capital requirements, partnerships, implementation timelines and long-term commercial viability.
Working with Pharmaceutical Industry Participants
We welcome discussions with qualified pharmaceutical manufacturers, API producers, raw-material suppliers, research organisations, laboratory specialists, technology providers and potential investment partners.
Manufacturing Partners
Connect with organisations that bring relevant API manufacturing expertise, technology, operational experience or facility-development capabilities.
Research Collaborators
Explore potential collaboration with qualified research teams, laboratory operators, scientific institutions and development partners.
Commercial & Investment Partners
Discuss distribution, sourcing, market access, joint ventures and investment opportunities aligned with our pharmaceutical growth priorities.
Building Long-Term Opportunities in Pharmaceuticals
For enquiries about API supply, pharmaceutical raw materials, plastic capsule shells, manufacturing opportunities, research collaborations or strategic investments, contact our team.
Advancing Pharmaceutical Supply. Investing in Future Medicines.
Origin Group is building its pharmaceutical business through the supply of active pharmaceutical ingredients, pharmaceutical raw materials and plastic capsule shells, while exploring investment opportunities in API manufacturing and pharmaceutical research and development.
Building a Platform Across the Pharmaceutical Value Chain
Pharmaceutical manufacturing depends on reliable access to quality ingredients and essential production materials. Origin Group currently focuses on the supply of APIs, pharmaceutical raw materials and plastic capsule shells.
Alongside this commercial activity, we are looking toward the next stage of development: investing in API manufacturing capabilities and establishing a research laboratory focused on the development of new medicines.
From Pharmaceutical Supply to Manufacturing and Research
Our ambition is to explore opportunities across the pharmaceutical value chain, connecting product supply today with potential manufacturing and research capabilities for the future.
Investment decisions will be guided by technical feasibility, regulatory requirements, commercial demand and long-term business viability.
Pharmaceutical Products & Raw Materials
Our current product focus includes pharmaceutical ingredients and capsule-related materials for businesses operating within the pharmaceutical supply chain. Product specifications, grades and availability are subject to individual product documentation and confirmation.
Active Pharmaceutical Ingredients
Supply of active pharmaceutical ingredients used as the active components in pharmaceutical formulations, subject to product availability and applicable quality documentation.
Pharmaceutical Raw Materials
Supply of pharmaceutical raw materials used in manufacturing and formulation processes, based on specific product requirements, applicable specifications and availability.
Plastic Capsule Shells
Supply of plastic capsule shells for pharmaceutical applications, subject to the required product type, dimensions, specifications and intended use.
Developing Pharmaceutical Manufacturing Capabilities
Origin Group is exploring investment opportunities that could expand its participation from product supply into pharmaceutical manufacturing and scientific research. These are future investment priorities and are subject to feasibility, approvals, funding and project development.
API Manufacturing Facility
We are looking to evaluate the development of an active pharmaceutical ingredient manufacturing facility, with the objective of building production capabilities and serving suitable domestic and international markets.
- Assessment of API product opportunities and market demand
- Evaluation of manufacturing technologies and production processes
- Facility design, equipment and quality-system planning
- Environmental, safety and regulatory compliance planning
- Evaluation of domestic and export-market opportunities
Drug Research & Development Laboratory
We are exploring the development of a pharmaceutical research laboratory focused on scientific work that could support the development of new medicines and future pharmaceutical products.
- Research capability and laboratory infrastructure assessment
- Evaluation of formulation and analytical development capabilities
- Scientific talent, specialist teams and research partnerships
- Evaluation of suitable research and development programmes
- Planning for applicable quality, safety and regulatory standards
Exploring the Next Generation of Pharmaceutical Capabilities
Our longer-term vision is to evaluate opportunities that connect pharmaceutical supply, manufacturing and research. The precise research focus will be determined through scientific, commercial and regulatory assessment.
Analytical Development
Explore capabilities for testing, characterisation and analytical methods to support pharmaceutical development and quality evaluation.
Formulation Research
Evaluate formulation research opportunities for suitable pharmaceutical dosage forms, subject to scientific expertise and project feasibility.
Research Partnerships
Explore collaboration with qualified scientists, universities, contract research organisations and pharmaceutical technology partners where strategically appropriate.
A Structured Approach to Pharmaceutical Expansion
Pharmaceutical manufacturing and drug research require specialised infrastructure, qualified personnel, rigorous quality systems and regulatory oversight. Our approach is to evaluate each opportunity against clear technical and commercial requirements.
01. Market Assessment
Study product demand, competitive positioning, customer needs and potential market access.
02. Technical Feasibility
Evaluate processes, facilities, equipment, technical expertise and operational requirements.
03. Quality & Compliance
Identify applicable manufacturing, laboratory, environmental, safety and regulatory requirements.
04. Investment Evaluation
Assess capital requirements, partnerships, implementation timelines and long-term commercial viability.
Working with Pharmaceutical Industry Participants
We welcome discussions with qualified pharmaceutical manufacturers, API producers, raw-material suppliers, research organisations, laboratory specialists, technology providers and potential investment partners.
Manufacturing Partners
Connect with organisations that bring relevant API manufacturing expertise, technology, operational experience or facility-development capabilities.
Research Collaborators
Explore potential collaboration with qualified research teams, laboratory operators, scientific institutions and development partners.
Commercial & Investment Partners
Discuss distribution, sourcing, market access, joint ventures and investment opportunities aligned with our pharmaceutical growth priorities.
Building Long-Term Opportunities in Pharmaceuticals
For enquiries about API supply, pharmaceutical raw materials, plastic capsule shells, manufacturing opportunities, research collaborations or strategic investments, contact our team.